LILRB1 and cancer: Immune-suppressive signaling nodes38,39 between the class I molecule, HLA-F, on both CAFs and cancer basal cells with the inhibitory receptor, leukocyte immunoglobulin like receptor B1 (LILRB1), on monocyte/macrophages were also noted in older TNBC patients.